#AMMF's Fast Fact booklet provides the most current and evidence based understanding of #CCA, along with treatment and diagnostic options, made for patients specifically. Download your copy at https://ammf.org.uk/fast-facts/#AMMF#CCAr email [email protected] for a hard copy. #Bileductcancer

AMMF Founder and CEO Dr Helen Morement opened AMMF’s 2026 European CCA Conference with a warm welcome to delegates attending our dedicated #patients and carers day at the conference. To watch Dr Helen Morement’s presentation: https://ammf.org.uk/ammf-conference-2026/#patients #bileductcancer #CCA

💜AMMF RoadMap – Research💜 At AMMF 2026 European #Cholangiocarcinoma Conference, we were proud to showcase AMMF’s first road map highlighting Research. 💜Without awareness, there is no funding 🔬Without funding, there is no research 🟪Without research, there is no cure #bileductcancer

Take a look at some of the insights shared from world leading experts highlighted during #AMMF's 2026 European #Cholangiocarcinoma #Conference. Raising awareness one 💜 at a time. #bileductcancer #AMMF2026

💜#AMMF 2026 European #Cholangiocarcinoma Conference 💜 Missed a session or want to revisit the discussions? All sessions from AMMF’s 2026 #CCA Conference are now available to watch via AMMF’s website. Visit AMMF’s website: https://ammf.org.uk/ammf-conference-2026/#AMMF#Cholangiocarcinoma#CCA#bileductcancer

The penultimate session at #AMMF’s 2026 European #Cholangiocarcinoma Conference is Fast Science, co-chaired by #CCA experts Professor Tim Kendall and Professor Kevin Gaston. Today’s sessions available tomorrow via the platform, register here: ammf.org.uk/ammf-confere... #AMMF2026

#AMMF is proud to support specialised research teams in their work to find the causes, methods of earlier diagnosis, and effective treatments for #cholangiocarcinoma. Today’s sessions on watch on demand from tomorrow via the platform, register here: ammf.org.uk/ammf-confere... #CCA

Interesting presentation on investigational breath-based biomarkers being evaluated for potential use in liver cancer detection. Dr Karagiannidis of Imperial College London outlined the underlying technology and ongoing validation work. #AMMF2026 #Biomarkers #LiverCancer

Welcome to Day 3 the final day of #AMMF’s conference! Let's make it count! You can catch up on Day 1 and Day 2 sessions via our app. To access the app, register via our website: https://ammf.org.uk/ammf-conference-2026/#AMMF’s #AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA

All AMMF’s sponsors supporting AMMF’s 2026 Conference have provided financial contribution only. They have not been involved in the content or any other aspect of the conference except as exhibitors and attendees. #AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA

As Day 2 of #AMMF’s 2026 European #Cholangiocarcinoma Conference comes to a close, we reflect on an insightful, information-packed day. Today’s sessions will be available to watch on demand tomorrow. Register for the platform: webapp.spotme.com/login/events... #AMMF2026 #bileductcancer #CCA

“Reliable #biomarkers are crucial for early detection of #CCA.” In a recorded presentation, Prof. Loilome (Khon Kaen University) shared mass spectrometry-based biomarker research identifying circulating tumour peptide patterns in hepatobiliary cancers. #AMMF2026 #Biomarkers #CancerResearch

Prof. Primrose @unisouthampton.bsky.social shared lessons from Thailand’s experience in #CCA #screening and #surgery. A clinical visit showcased a high standard of surgery with excellent operative expertise, alongside a unique prevention and screening programme. #AMMF2026 #GlobalHealth

Spotlight on CCA in Wales - Ms Trish Duncan (University Hospital of Wales) highlighted variation in #care pathways and access across #Wales. #CCA does not currently have a national optimal pathway in Wales. “We need a greater awareness of CCA and improved reporting.” #AMMF2026

💜 #AMMF 2026 European Cholangiocarcinoma Conference 💜 The Day 1 sessions are now available to watch on AMMF’s conference platform. For more information and to register, visit: https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference#AMMF #bileductcancer #CCA

“Variation in adherence to best practice guidelines between centres persist.” Ms Jane McClements @belfasttrust.bsky.social presented results from the UK nationwide CAPBIL study evaluating care and outcomes in patients with intrahepatic CCA. #AMMF2026 #BestPractice #CCA

"The complexity of #CCA surgery varies depending on tumour location with perihilar CCA remaining one of the most challenging subtypes to manage." Prof. Primrose (@unisouthampton.bsky.social) explored how surgical management for #CCA continues to evolve. #AMMF2026 #Surgery #cholangiocarcinoma

“There is an urgent need for standardised guidelines for the management of #gallbladder cancer in the UK.” Prof. Gomez @uniofnottingham.bsky.social shared an overview of key recommendations from the British Society of Gastroenterology on #GBC diagnosis and management. #AMMF2026

Prof. Khan from Imperial College Healthcare presented the Asp-PSC trial, an ongoing study investigating whether low-dose aspirin could reduce the risk of primary sclerosing cholangitis (PSC)-associated cancers in patients with #PSC and inflammatory bowel disease (IBD). #AMMF2026

Prof. Hawkins of University College London shared the latest advances and data exploring the potential role of radiotherapy across the treatment landscape for #CCA. “It would be nice to have a biomarker to help determine who should receive radiotherapy, but we are not there yet.” #AMMF2026

Dr Matt Evans (@uhsft.bsky.social) highlighted why molecular profiling is so important in #CCA care. “Early molecular testing not only helps patients get access to the right treatment, but it also helps healthcare professionals make an accurate diagnosis of CCA.” #AMMF2026 #PrecisionMedicine

Shane Cohen-Murray from the Department of Health and Social Care opened Day 2 with insights into the #NationalCancerPlan and the importance of improving outcomes for people affected by cancer, including rare and less common cancers such as cholangiocarcinoma. #AMMF2026 #Cholangiocarcinoma

All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.

Join us as we kick off Day 2 with Cholangiocarcinoma-UK as we highlight the rapidly evolving treatment landscape of #CCA. #AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer

All #AMMF’s sponsors supporting AMMF’s 2026 Conference have provided financial contribution only. They have not been involved in the content or any other aspect of the conference except as exhibitors and attendees #AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA

As Day 1 of #AMMF’s 2026 European #Cholangiocarcinoma Conference comes to a close, we reflect on an inspiring start to our 3-day event. Today’s sessions will be available to watch on demand from tomorrow. To access the platform: webapp.spotme.com/login/events... #AMMF2026 #bileductcancer #CCA

“Pathology is hidden. You won’t ever meet anyone in the pathology department, but there are maybe 30-40 people involved.” Prof. Tim Kendall (@edinburgh-uni.bsky.social) highlighted the often unseen but critical role of pathology in the #cholangiocarcinoma patient journey. #AMMF2026 #Pathology

“Transplant is considered for quite a restricted subset of patients with CCA.” Prof. Douglas Thorburn (@uclh.bsky.social) highlighted the evolving role of liver transplantation in cholangiocarcinoma care. #AMMF2026 #LiverTransplant #CCA

“For rare cancers, there is enormous heterogeneity in assessing patients’ quality of life.” Catarina S. Padilla from the Netherlands Cancer Institute presented research into the health-related quality of life of patients with cholangiocarcinoma at #AMMF2026. #AMMF2026 #QoL

“It is important to have a robust multidisciplinary approach to making decisions about the treatment of patients.” Mr Hassan Malik (@nhsuhlg.bsky.social) shared the latest thinking on surgery and multidisciplinary care in cholangiocarcinoma. #AMMF2026 #Surgery #Cholangiocarcinoma

Dr Meissner from Velindre Cancer Centre and Cardiff University explored the potential of liquid biopsy (ctDNA) in CCA diagnosis and monitoring. “A liquid biopsy can capture the molecular profile of a patients’ tumour, complementary to tissue biopsy.” #AMMF2026 #LiquidBiopsy #CCA

“Early access to therapy is critical and molecular testing is absolutely essential.” Prof. John Bridgewater from UCL Cancer Institute, University College London explained how targeted therapies and immunotherapies are changing treatment for CCA. #AMMF2026 #PrecisionMedicine #bileductcancer

#AMMF’s Founder and CEO Dr Helen Morement warmly welcomed today’s delegates to AMMF’s 2026 European Cholangiocarcinoma Conference. “Patients are always at the heart of everything we do – today is about you.” #AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA

All #AMMF’s sponsors supporting AMMF’s 2026 Conference have provided financial contribution only. They have not been involved in the content or any other aspect of the conference except as exhibitors and attendees. Thank you for your continued support 💜 #CCA

Welcome to Day 1 of #AMMF’s European CCA Conference 2026! Watch on demand day 1 of our patient and carers sessions tomorrow: https://ammf.org.uk/ammf-conference-2026/#AMMF’s #AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA

Can’t make #AMMF’s 2026 European Conference in person this year? You can still be a part of it. Register for Watch on Demand and be notified as soon as sessions become available. 🔗https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference#AMMF’s #bileductcancer #cca

We’re just one week away from the AMMF 2026 Conference 13th - 15th May! We can’t wait to welcome you to this pivotal event. Don’t miss out—sign up now and join us for three days of learning, sharing, and shaping the future of CCA treatment and care! https://ammf.org.uk/ammf-conference-2026/

💜#AMMF 2026 HPB Nurse Study Day - 1 week to go💜 📅Tuesday 12 May 2026 📍Radisson Blu Hotel, Stansted Raising awareness one 💜 at a time. #bileductcancer #CCA #cholangiocarcinoma

Can’t make #AMMF’s 2026 European #Cholangiocarcinoma Conference in person this year? No problem you can still be a part of it. Register for watch on demand today: 🔗https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference#AMMF’s#Cholangiocarcinoma#bileductcancer #CCA

🚨Spaces available – #HPB Nurse Study Day 🚨 Spaces have become available due to recent cancellations for #AMMF's HPB Nurse Study Day. 📅Tuesday 12 May 2026 📍Radisson Blu, Stansted, London If you would like to secure a place, email [email protected] as soon as possible. #CCA

AMMF welcomes NICE’s recommendation that a new life-extending targeted treatment for HER2-positive biliary tract cancers, zanidatamab, should be used by the NHS. Read more at https://ammf.org.uk/2026/04/21/zanidatamab-approved-for-nhs-use-by-nice/

On Day 3 of #AMMF’s 2026 Conference, hear from leading experts on: 🔬Novel #therapies and research 🧪AMMF-funded #research 🦠Researchers showcasing their latest projects Register today. 🔗https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference#AMMF’s#therapies#research#bileductcancer

Just 3 weeks until #AMMF’s 2026 HPB Nurse Study Day (12 May)! We are looking forward to welcoming nurses interested in #cholangiocarcinoma for this #CCA education event. If you have not received confirmation, please email: [email protected] https://ammf.org.uk/hpb-nurse-study-day-2026/

#AMMF is disappointed that NICE has published draft guidance, recommending #larotrectinib should not be used by the NHS for patients with solid tumours that have NTRK gene fusions. Read more at https://ammf.org.uk/2026/04/10/nice-publishes-draft-recommendation-for-larotrectinib/#AMMF#larotrectinib#CCA #bileductcancer

#AMMF 2026 European #Cholangiocarcinoma Conference – 1 month to go 📅13–15 May 2026 📍Radisson Blu Hotel, Stansted 🔗https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference Explore the full programme: 🔗 https://ammf.org.uk/ammf-conference-2026/#AMMF#Cholangiocarcinoma#bileductcancer#CCA

Meet the experts in the field of CCA at #AMMF’s 2026 European Cholangiocarcinoma Conference. To register for your place: 📅13 – 15 May 2026 📍The Radisson Blu, Stansted, UK 🔗 https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference#AMMF’s #bileductcancer #CCA

💜International Aspects of #CCA💜 Hear from leading #international experts at #AMMF’s 2026 European #Cholangiocarcinoma Conference. 📅13 – 15 May 2026 📍Radisson Blu Hotel, Stansted, UK 🔗 https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference#CCA💜#international#AMMF’s#Cholangiocarcinoma#bileductcancer

Meet the experts in the field of cholangiocarcinoma (CCA) at AMMF’s 2026 European Cholangiocarcinoma Conference. 📅13 – 15 May 2026 📍The Radisson Blu, Stansted, UK 🔗 https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference #bileductcancer

Join us at #AMMF’s 2026 European Cholangiocarcinoma Conference. Be a part of Shaping the future of #cholangiocarcinoma (#CCA). 📅13 – 15 May 2026 📍Radisson Blu Hotel, Stansted, UK 🔗 https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference#AMMF’s#cholangiocarcinoma#CCA)#bileductcancer

Meet the experts in the field of cholangiocarcinoma (CCA) at AMMF’s 2026 European Cholangiocarcinoma Conference. 📅13 – 15 May 2026 📍The Radisson Blu, Stansted, UK 🔗 https://webapp.spotme.com/login/eventspace/2026-ammf-european-cholangiocarcinoma-conference #bileductcancer